Rowland Carmichael Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $237K | Sell |
6,586
-264
| -4% | -$9.5K | 0.08% | 271 |
|
|
2020
Q3 | $262K | Buy |
6,850
+39
| +0.6% | +$1.49K | 0.1% | 223 |
|
|
2020
Q2 | $239K | Buy |
6,811
+467
| +7% | +$16.4K | 0.1% | 226 |
|
|
2020
Q1 | $207K | Sell |
6,344
-179
| -3% | -$5.84K | 0.11% | 228 |
|
|
2019
Q4 | $295K | Hold |
6,523
| – | – | 0.1% | 228 |
|
|
2019
Q3 | $265K | Sell |
6,523
-1,758
| -21% | -$71.4K | 0.09% | 238 |
|
|
2019
Q2 | $356K | Hold |
8,281
| – | – | 0.12% | 182 |
|
|
2019
Q1 | $318K | Sell |
8,281
-2,431
| -23% | -$93.4K | 0.12% | 186 |
|
|
2018
Q4 | $379K | Hold |
10,712
| – | – | 0.17% | 146 |
|
|
2018
Q3 | $412K | Hold |
10,712
| – | – | 0.16% | 153 |
|
|
2018
Q2 | $350K | Hold |
10,712
| – | – | 0.15% | 181 |
|
|
2018
Q1 | $293K | Hold |
10,712
| – | – | 0.16% | 175 |
|
|
2017
Q4 | $266K | Buy |
10,712
+197
| +2% | +$4.89K | 0.14% | 201 |
|
|
2017
Q3 | $307K | Hold |
10,515
| – | – | 0.17% | 167 |
|
|
2017
Q2 | $291K | Hold |
10,515
| – | – | 0.17% | 168 |
|
|
2017
Q1 | $262K | Sell |
10,515
-10,475
| -50% | -$261K | 0.16% | 170 |
|
|
2016
Q4 | $454K | Hold |
20,990
| – | – | 0.27% | 120 |
|
|
2016
Q3 | $500K | Hold |
20,990
| – | – | 0.32% | 103 |
|
|
2016
Q2 | $491K | Buy |
+20,990
| New | +$491K | 0.31% | 109 |
|